UC BON.CAP.CERT. 06/25 MRK/ DE000HD2H1Q8 /
2024-05-23 1:46:50 PM | Chg.+0.910 | Bid2:13:07 PM | Ask2:13:07 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
157.710EUR | +0.58% | 157.640 Bid Size: 2,000 |
157.690 Ask Size: 2,000 |
MERCK KGAA O.N. | - - | 2025-06-27 | Call |
GlobeNewswire
1:00 PM
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
1:00 PM
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA